Table 1. Snapshot of North America Point of Care (PoC) Molecular Diagnostics Market, 2019-2030 18
Table 2. Growth Rate of World Real GDP, 2017-2021 22
Table 3. Main Product Trends and Market Opportunities in North America Point of Care (PoC) Molecular Diagnostics Market 34
Table 4. North America Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 43
Table 5. North America Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 48
Table 6. North America Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn 50
Table 7. North America Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 57
Table 8. North America Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn 60
Table 9. North America Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn 69
Table 10. North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn 77
Table 11. U.S. Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 81
Table 12. U.S. Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 81
Table 13. U.S. Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 81
Table 14. Canada Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 84
Table 15. Canada Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 84
Table 16. Canada Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 84
Table 17. Mexico Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 86
Table 18. Mexico Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 86
Table 19. Mexico Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 86
Table 20. Breakdown of North America Market by Key Vendor, 2019, % 89
Table 21. Abacus Diagnostica Oy: Company Snapshot 92
Table 22. Abacus Diagnostica Oy: Business Segmentation 92
Table 23. Abacus Diagnostica Oy: Product Portfolio 93
Table 24. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn 93
Table 25. Abacus Diagnostica Oy: Recent Developments 93
Table 26. Risk Evaluation for Investing in North America Market, 2019-2030 113
Table 27. Critical Success Factors and Key Takeaways 116

LIST OF FIGURE

Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. North America Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of North America Point of Care (PoC) Molecular Diagnostics Market 26
Figure 8. World Number of Deaths by Cause in 2017 29
Figure 9. World Number of Deaths from Cancers in 2017 30
Figure 10. Primary Restraints and Impact Factors of North America Point of Care (PoC) Molecular Diagnostics Market 31
Figure 11. Investment Opportunity Analysis 35
Figure 12. Porters Fiver Forces Analysis of North America Point of Care (PoC) Molecular Diagnostics Market 38
Figure 13. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue 43
Figure 14. North America Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 44
Figure 15. North America Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn 45
Figure 16. North America Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn 46
Figure 17. North America Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn 47
Figure 18. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue 48
Figure 19. North America Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%) 49
Figure 20. North America Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn 50
Figure 21. North America Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn 51
Figure 22. North America Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn 52
Figure 23. North America Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn 53
Figure 24. North America Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn 54
Figure 25. North America Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn 55
Figure 26. North America Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn 56
Figure 27. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue 57
Figure 28. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 58
Figure 29. North America Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn 59
Figure 30. North America Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn 61
Figure 31. North America Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn 62
Figure 32. North America Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn 63
Figure 33. North America Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn 64
Figure 34. North America Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn 65
Figure 35. North America Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn 66
Figure 36. North America Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn 67
Figure 37. North America Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn 68
Figure 38. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue 69
Figure 39. North America Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 70
Figure 40. North America Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn 71
Figure 41. North America Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn 72
Figure 42. North America Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn 73
Figure 43. North America Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn 74
Figure 44. Breakdown of North America Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue 77
Figure 45. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 78
Figure 46. U.S. Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 80
Figure 47. Canada Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 83
Figure 48. Point of Care (PoC) Molecular Diagnostics Market in Mexico, 2015-2030, $ mn 85
Figure 49. Growth Stage of North America Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period 87